Ensign Peak Advisors’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$66.8K Hold
2,040
﹤0.01% 1687
2026
Q1
$72.1K Hold
2,040
﹤0.01% 1633
2025
Q4
$82.8K Sell
2,040
-8,550
-81% -$372K ﹤0.01% 1613
2025
Q3
$498K Sell
10,590
-700
-6% -$36.3K ﹤0.01% 1387
2025
Q2
$588K Hold
11,290
﹤0.01% 1511
2025
Q1
$682K Hold
11,290
﹤0.01% 1447
2024
Q4
$773K Hold
11,290
﹤0.01% 1464
2024
Q3
$812K Hold
11,290
﹤0.01% 1436
2024
Q2
$783K Hold
11,290
﹤0.01% 1438
2024
Q1
$904K Sell
11,290
-570
-5% -$50.8K ﹤0.01% 1397
2023
Q4
$1.3M Buy
11,860
+200
+2% +$20.7K ﹤0.01% 1178
2023
Q3
$1.18M Hold
11,660
﹤0.01% 1070
2023
Q2
$1.58M Hold
11,660
﹤0.01% 963
2023
Q1
$1.21M Buy
11,660
+700
+6% +$67.7K ﹤0.01% 1088
2022
Q4
$971K Sell
10,960
-450
-4% -$37.3K ﹤0.01% 1180
2022
Q3
$915K Hold
11,410
﹤0.01% 1118
2022
Q2
$1.09M Hold
11,410
﹤0.01% 1075
2022
Q1
$1.7M Hold
11,410
﹤0.01% 946
2021
Q4
$1.62M Sell
11,410
-12,210
-52% -$1.73M ﹤0.01% 1047
2021
Q3
$3.09M Hold
23,620
0.01% 867
2021
Q2
$3.25M Hold
23,620
0.01% 844
2021
Q1
$3.08M Hold
23,620
0.01% 844
2020
Q4
$2.65M Hold
23,620
0.01% 899
2020
Q3
$1.86M Hold
23,620
﹤0.01% 1008
2020
Q2
$1.7M Hold
23,620
﹤0.01% 1059
2020
Q1
$1.35M Hold
23,620
﹤0.01% 1024
2019
Q4
$2.64M Buy
+23,620
New +$2.52M 0.01% 927

Other funds holding CNMD

Ensign Peak Advisors's CNMD Position: Q2 2026 in Review

Ensign Peak Advisors held its CONMED (CNMD) position steady in Q2 2026 at 2,040 shares worth $66.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1687.

Ensign Peak Advisors first reported a position in CNMD in Q4 2019 and has held it in 27 quarters since. The position peaked at $3.25M in Q2 2021. 246 funds tracked by Wall St. Rank hold CNMD as of Q2 2026.

  • Ensign Peak Advisors held 2,040 shares of CONMED worth $66.8K as of Q2 2026.
  • Ensign Peak Advisors left its CONMED share count unchanged in Q2 2026.
  • CONMED made up ﹤0.01% of Ensign Peak Advisors's portfolio in Q2 2026, its #1687 holding.
  • Ensign Peak Advisors first reported a position in CONMED in Q4 2019 and has held it in 27 quarters since.
  • Ensign Peak Advisors's CONMED position peaked at $3.25M in Q2 2021.
  • 246 funds tracked by Wall St. Rank held CONMED as of Q2 2026.

Based on Ensign Peak Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.